Published December, 2012
By M.A. Hayat
Publisher: Springer
Series: Tumors of the Central Nervous System
Rating:
Availability: Available

This volume joins its fellow publications in a valuable series that fully explores controversies and debates in CNS cancer therapy, and furthers the scientific quest for effective therapies to combat cancer in all its forms.

---

Published June, 2012
By M. A. Hayat and M.A. Hayat
Publisher: Springer
Series: Tumors of the Central Nervous System
Rating:
Availability: Available

With much more besides, including discussion of the molecular mechanisms that result in resistance to chemotherapy in medulloblastoma, this volume and its companions have a positive role to play in inspiring a new generation of researchers to design new drugs that are better targeted-and thus more effective.

---

Published February, 2012
By M. A. Hayat and M.A. Hayat
Publisher: Springer
Series: Tumors of the Central Nervous System
Rating:
Availability: Available

Various aspects, including diagnosis, therapy, and prognosis, of two brain tumors (meningioma and schwannoma) , of brain tumors are discussed in this volume. Diagnosis of facial nerve schwannoma, vestibular schwannoma, and intermediate nerve schwannoma is explained.

---

Published February, 2012
By M. A. Hayat and M.A. Hayat
Publisher: Springer
Series: Tumors of the Central Nervous System
Rating:
Availability: Available

This volume contains information on the diagnosis, therapy, and prognosis of spinal tumors. Symptoms, radiological features, and clinicopathological parameters of spinal cord tumors are explained. Introduction to new technologies and their applications to spinal cord tumor diagnosis, treatment, and therapy assessment are explained.

---

Published October, 2011
By M. A. Hayat and M.A. Hayat
Publisher: Springer
Series: Tumors of the Central Nervous System
Rating:
Availability: Available

This volume mainly contains information on the diagnosis, therapy, and prognosis of brain tumors. Role of MicroRNA in distinguishing primary tumors from metastatic primary tumors is discussed. The complexity of tumor to tumor transfer is explained;

---

Published September, 2011
By M. A. Hayat and M.A. Hayat
Publisher: Springer
Series: Tumors of the Central Nervous System
Rating:
Availability: Available

The most recent developments in diagnostic and therapeutic aspects of Gliomas (glioblastoma) in the brain are presented. The role of molecular signaling in the CNS cancer development is explained, including cell death signaling in glioblastoma multiforme.

---

Published May, 2011
By M. A. Hayat and M.A. Hayat
Publisher: Springer
Series: Tumors of the Central Nervous System
Rating:
Availability: Available

The classification of brain tumors is up-dated using magnetic resonance spectroscopy technology. for example, , brain metastasis from breast cancer, lung cancer, and renal cancer is discussed. Also, is discussed the impact of PET using radiolabeled amino acids on brain tumors.

---

Published April, 2011
By M. A. Hayat and M.A. Hayat
Publisher: Springer
Series: Tumors of the Central Nervous System
Rating:
Availability: Available

Various types of imaging modalities, including PET and SPECT, to diagnose gliomas in general and glioblastoma in particular in patients are explained in detail. Conventional as well as fluorescent-guided resection techniques for high-grade, recurrent malignant gliomas are detailed.

---

Published March, 2011
By M. A. Hayat
Publisher: Springer
Series: Tumors of the Central Nervous System
Rating:
Availability: Available

The most recent developments in diagnostic and therapeutic aspects of Gliomas (Glioblastoma) in the brain are presented. The identification and validation of brain cancer (glioblastoma) genes are discussed. The use of surgical resection, chemotherapy (e.g., temozolomide), immunotherapy, and radiotherapy for malignant glioblastoma are pointed out.

---